Clinical manifestations associated with HTLV type I infection: A cross-sectional study

AIDS Research and Human Retroviruses

Volumn 23, Issue 3, 2007, Pages 365-371

  Caskey, Marina F ^a   Morgan, Daniel J ^a   Porto, Aurelia F ^b   Giozza, Silvana P ^b   Muniz, Andre L ^b   Orge, Glória O ^b   Travassos, María J ^b   Barrón, Yolanda ^a   Carvalho, Edgar M ^b   Glesby, Marshall J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARM WEAKNESS; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GINGIVITIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PERIODONTITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; T CELL LEUKEMIA; XEROSTOMIA;

ADULT; ARTHRALGIA; BLOOD DONORS; CARRIER STATE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; HYPESTHESIA; IMPOTENCE; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NOCTURIA; ODDS RATIO;

EID: 34247182993     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0140     Document Type: Article

References (28)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, and Murphy EL: Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 2005;24:6058-6068.
3. Dourado I, Alcantara LC, Barreto M, Teixeira MG, and Galvao-Castro B: HTLV-I in the general population of Salvador, Brazil. A city with African ethnic and sociodemogrphic characteristics. J Acquir Immune Defic Syndr 2003;34:527-531.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, and de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410.
5. Osame M, Usuku K, Izumo S, et al.: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;1:1031-1032.
6. Manns A, Hisada M, and La Grenade L: Human T-lymphotropic virus type I infection. Lancet 1999;353:1951-1958.
7. Araujo A, Andrade-Filho A, Castro-Costa C, Menna-Barreto M, and Almeida S: HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: A nationwide survey. HAM/TSP Brazilian Study Group. J Acquir Immune Defic Syndr Hum Retroviral 1998;19:536-541.
8. Castro NM, Rodrigues W Jr, Muniz A, Luz GO, Porto AM, Machado A, and Carvalho EM: Neurogenic bladder as the first manifestation of HTLV-I infection. Ciência e Saúde 2003;3:66-69.
9. World Health Organization: Report of the scientific group on HTLV-I and associated disease. Kagoshima, Japan, December 1988: Virus disease. Human T lymphotropic virus type I (HTLV-I). Wkly Epidem Rec 1989;49:382-383.
10. Mochizuki M, Watanabe T, Yamaguchi K, et al.: HTLV-I uveitis. A distinct clinical entity caused by HTLV-1. Jpn J Cancer Res 1992;83:236-239.
11. Eguchi K, Matsuoka N, Ida H, et al.: Primary Sjogren's syndrome with antibodies to HTLV-I: Clinical and laboratory features. Ann Rheum Dis 1992;51:769-776.
12. Murphy EL, Baoguang W, Sacher RA, et al.: Respiratory and urinary tract infections, arthritis and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis 2004;10:109-116.
13. Marsh B: Infectious complications of human T cell leukemia/lymphoma virus type I infection. Clin Infect Dis 1996;23:138-145.
14. LaGrenade L, Hanchard B, Fletcher V, Cranston B, and Blattner W: Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancet 1990;336:1345-1347.
15. Carvalho EM and Porto AF: Epidemiological and clinical interaction between HTLV-I and Strongyloides stercoralis. Parasite Immunol 2004;26:487-497.
16. Taylor GP: Pathogenesis and treatment of HTLV-I-associated myelopathy. Sex Transm Infect 1998;74:316-322.
17. Azevedo ES, Fortuna CM, Santos MG, et al.: Spread and diversity of human populations in Bahia, Brazil. Hum Biol 1982;54:329-341.
18. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-1452
19. Osame M: Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Human retrovirology: HTLV. (Blattner W, ed.). Raven Press, New York, 1990, pp. 191-197.
20. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, and Pena BM: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11(6): 319-326.
21. Bohannon RW and Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-207.
22. Murphy EL, Wilks R, Morgan OS, et al.: Health effects of human T-lymphotropic virus type I (HTLV-I) in a Jamaican cohort. Int J Epidemiol 1996;25:1090-1097.
23. Murphy EL, Glynn SA, Fridey J, et al.: Increased incidence of infectious diseases during prospective follow up of human T-lymphotropic virus type II- and I-infected blood donors. Arch Intern Med 1999;159:1485-1491.
24. Orland JR, Engstrom J, Fridey J, et al.: Prevalence and clinical features of HTLV neurological disease in the HTLV outcomes study. Neurology 2003;61:1588-1594.
25. Hattori T, Sakakibara R, Yamanishi T, Yasuda K, and Hirayama K: Micturitional disturbance in human T-lymphotropic virus type-1-associated myelopathy. J Spinal Disord 1994;7:255-258.
26. Nagai M, Usuku K, Matsumoto W, et al.: Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998;4:586-593.
27. Santos SB, Porto AF, Muniz AL, et al.: Exacerbated inflammatory cellular immune response characteristic of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 2004;4:7-14.
28. Yakova M, Lezin A, Dantin F, et al.: Increased proviral load in HTLV-I-infected patients with rheumatoid arthritis or connective tissue disease. Retrovirology 2005;2:4-12.